Preparation method of vitamin C crystals with small particle size and uniform morphology
By using water-alcohol solvent composite solvent and constant temperature and constant speed treatment methods, the uneven particle size distribution and oxidation problems of small-particle vitamin C crystals are solved, and the preparation of small-particle vitamin C crystals with high purity and high yield is achieved. It is suitable for Pharmaceutical and food industries.
Patent Information
- Application Number
- CN202411040872.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-31
- Publication Date
- 2024-11-22
AI Technical Summary
The prior art is difficult to effectively control the particle size distribution and stability of small-particle vitamin C crystals, which can easily lead to oxidation during the screening process and affect product quality.
Using water-alcohol solvent composite solvent, crystallization and crystallization are carried out by constant-speed heating and constant-speed cooling to obtain small-grained vitamin C crystals with a main particle size D50 ranging from 95 to 100μm, avoiding particles during screening. Dimensions are difficult to control and oxidize.
The particle size distribution of vitamin C crystals is controlled, the product yield is high (over 90%), and the purity is high (up to 99% HPLC purity is simplified, and the production process is reduced and the cost is reduced. It is suitable for the industrialization of pharmaceutical preparations and food additives. Production.
Smart Images

Figure CN118994064A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of crystal technology, and in particular to a method for preparing vitamin C crystals with small particle size and uniform morphology. Background Art
[0002] The information disclosed in the background of the present invention is intended to increase the understanding of the overall background of the present invention, and the disclosure should not necessarily be regarded as an admission or any form of suggestion that the information has become the prior art known to ordinary technicians in the field.
[0003] Vitamin C (abbreviated as V C ), also known as L-ascorbic acid, plays an important role in the fields of pharmaceutical preparations and food additives. It is an indispensable substance for maintaining human health, a catalyst for redox reactions in living cells, participates in various metabolisms in the body, and has the physiological effect of promoting the synthesis of various hormones in the body.
[0004] The particle size of vitamin C crystals will affect its dissolution and release in the pharmaceutical composition, and further affect the bioavailability of the drug in the human body. In order to meet the different application requirements of vitamin C in the fields of pharmaceutical preparations, food additives, etc., commercially available vitamin C often needs to be screened out of vitamin C of different particle sizes. The inventors found that the current small-particle vitamin C is often obtained by screening, but the particle size of vitamin C is difficult to control, the particle size distribution is uneven, and the crystal form and stability may also change during the screening process; at the same time, because vitamin C has a strong antioxidant activity, the screening process is prone to cause vitamin C oxidation, thereby affecting the purity of the product quality during the screening process.
[0005] Although there have been a lot of studies on vitamin C crystal dynamics, they are mainly focused on the establishment of vitamin C crystal dynamics model and parameter regulation. There are few studies involving the controllable regulation of the particle size and morphology of small-particle vitamin C, especially the study of D50, crystal purity, particle size distribution, yield and stability of the crystal process. Summary of the invention
[0006] Based on the above findings of the inventors, the inventors realize that controlling the particle size of vitamin C crystals and how to better obtain small-particle vitamin C are of great significance for the production and application in the fields of pharmaceutical preparations, food additives, etc. Based on such considerations, the inventors imagine that if small-particle products can be directly obtained in the crystal link, it will bring great convenience to various productions of vitamin C. Therefore, the present invention provides a method for preparing small-particle vitamin C crystals, which can obtain vitamin C crystals with good powder flowability and controllable particle size distribution (the main particle size D50 can be between 95 and 100 μm) without screening, and the method has a high product yield (more than 90%), a high product purity (HPLC purity is more than 99%), a simple and easy method, low cost, and is easily applicable to industrial production of pharmaceutical preparations, food additives, etc.
[0007] Specifically, the present invention provides the following technical features, and the combination of one or more of the following technical features constitutes the technical solution of the present invention.
[0008] In the first aspect of the present invention, the present invention provides a method for preparing small-particle vitamin C crystals. In the method of the present invention, unless otherwise specified, the small-particle vitamin C crystals of the present invention refer to a main particle size D50 of 95 to 100 μm.
[0009] In this technical field, ordinary technicians know that D50 refers to the particle size corresponding to when the cumulative particle size distribution percentage of a sample reaches 50%. Its physical meaning is that particles with a particle size greater than this value account for 50%, and particles with a particle size less than this value also account for 50%. Therefore, D50 is also called the median particle size or median particle size, and is often used to indicate the average particle size of a powder.
[0010] Vitamin C crystal size is an important indicator of quality control. The dissolution of the drug directly affects the absorption and utilization of the drug in the body. If the drug is not easy to dissolve or the dissolution rate is extremely slow, the absorption rate or degree of the drug in the preparation may be problematic. On the other hand, if the drug dissolves too quickly, significant adverse reactions may occur, or the time to maintain the efficacy of the drug may be greatly shortened. During the research process of the present invention, the inventor found that when the D50 of the vitamin C crystal is higher than 100 μm, the dissolution release of the preparation will obviously slow down, and when the D50 is lower than 95 μm, the dissolution release of the preparation will significantly speed up. Therefore, with respect to vitamin C crystals, its D50 is too high or too low, which will affect the dissolution of the preparation. In the present invention, the inventor found in the process of preparing its pharmaceutical preparation or food additive with vitamin C crystals that when the D50 of vitamin C is between 95 and 100 μm, the dissolution of the drug can be well achieved, and the preparation process is more conducive to reducing the loss of materials and ensuring the stability of quality.
[0011] In an embodiment of the present invention, the preparation method comprises:
[0012] Vitamin C is added into the solvent, stirred, and heated to the dissolving temperature; then, the crystals are grown at a constant temperature at the dissolving temperature; the temperature is then lowered to crystallize, and a small-size vitamin C crystal product is obtained by filtering and drying.
[0013] The solvent is a water-alcohol composite solvent, the alcohol solvent is methanol, ethanol, isopropanol or n-butanol, and the mass fraction of the alcohol solvent in the water-alcohol composite solvent is 1-10%.
[0014] The mass ratio of the vitamin C to the solvent is 35-45%.
[0015] The dissolving temperature is 50-70° C., and the constant temperature crystal growing time is 10-90 min.
[0016] The cooling crystallization temperature is 30-40°C.
[0017] The temperature rise is a constant rate temperature rise, and the constant rate temperature rise is 0.5-1.0°C / min.
[0018] The cooling is performed at a constant rate, and the constant rate of cooling is 0.2-0.4°C / min.
[0019] In the embodiments of the present invention, the arrangement of each step and the selection of solvent in the present invention are extremely critical because they directly affect the morphology and particle size of the product.
[0020] In an embodiment of the present invention, the selection of the mass fraction of the alcohol solvent in the water-alcohol solvent composite solvent is an important factor in obtaining the expected morphology and particle size. An increase in the mass fraction of the alcohol solvent is conducive to the formation of small-diameter vitamin C crystal nuclei, resulting in smaller particle size. When the mass fraction of the alcohol solvent is lower than 1%, the particle size has little effect; when the mass fraction of the alcohol solvent is higher than 10%, the particle size decreases significantly.
[0021] The inventors found during the research that when other solvents such as water or alcohol solvents are used to dissolve vitamin C, it is not only difficult to obtain the expected particle size, but also the yield and purity of the product are often unsatisfactory. The purity of the product is even lower than that of the untreated product. The main particle size D50 is often too large, exceeding 100 μm, and particle size screening is still required for preparation. In addition, the inventors also tried other crystallization solvents such as acetone, but the product yield was too low, less than 90%, and the main particle size D50 was often too small, less than 95 μm.
[0022] In the embodiment of the present invention, the time of the above-mentioned constant temperature crystal cultivation is an important factor affecting the expected morphology. The inventors found that during the constant temperature crystal cultivation process, the crystal growth rate is relatively small, while the nucleation rate is always large. As the supersaturation of the solution decreases, the growth rate continues to decrease, while the suspension density of the slurry gradually increases, so that the nucleation has a maximum value. Therefore, as time goes by, the morphology gradually becomes regular and smooth, and becomes a cubic structure.
[0023] In some embodiments of the present invention, the crystallization temperature is not higher than 40° C.; further, in some embodiments of the present invention, the crystallization temperature is 30-40° C. A crystallization temperature that is too low, such as below 30° C., will result in incomplete morphology, low product yield and low product purity, while a crystallization temperature that is too high, such as above 40° C., will easily cause poor stability and make it difficult to obtain the expected morphology and particle size.
[0024] In some embodiments of the present invention, the drying is vacuum drying, the drying temperature is 30-60° C., and the drying time is 1 to 5 hours.
[0025] More specifically, in some preferred embodiments of the present invention, the preparation method comprises:
[0026] Water-methanol is used as solvent, the mass fraction ratio of methanol to water is 1-10%, vitamin C with a mass fraction of 35-45% of the solution system is weighed, added into a crystallizer, heated to 50-70°C at a constant rate of 0.5-1.0°C / min under stirring until the vitamin C is dissolved, and then the crystal is grown at a constant temperature for 15-90 minutes. Then the temperature is lowered to 30-40°C at a constant rate of 0.2-0.4°C / min for crystallization, filtered and vacuum dried at 30-60°C for 5 hours to obtain a small-size vitamin C crystal product.
[0027] Compared with the prior art, the advantages of the present invention are:
[0028] The method of the present invention can obtain vitamin C crystals with controllable particle size distribution (main particle size can be between 95 and 100 μm) without crushing, and the method has high product yield (90%), high product purity (99%), is simple and easy to operate, and the conditions are easy to control (the temperature of the entire process of the method does not need to be higher than 70° C., and there is no need to adjust the pH), the cost is low, and small-particle vitamin C crystals can be easily applied to industrial production of pharmaceutical preparations, food additives, etc. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] The accompanying drawings constituting a part of the present invention are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute an improper limitation of the present invention. The embodiments of the present invention are described in detail below in conjunction with the accompanying drawings, wherein:
[0030] Figure 1 The particle size distribution diagram of vitamin C prepared in Example 1 of the present invention;
[0031] Figure 2 This is the particle size distribution diagram of commercially available small-particle vitamin C;
[0032] Figure 3 The physical pictures of vitamin C (a) prepared in Example 1 of the present invention and the commercially available product (b);
[0033] Figure 4 The SEM images of the vitamin C (a) prepared in Example 1 of the present invention and the commercially available product (b);
[0034] Figure 5 The XRD spectra of vitamin C prepared in Examples 1 to 3 of the present invention are shown. DETAILED DESCRIPTION
[0035] The vitamin C in the following examples of the present invention is from Shandong Zibo Luwei Pharmaceutical Group, and the alcohol solvents used are all analytically pure.
[0036] Example 1
[0037] Using water-methanol as solvent, the ratio of methanol to water mass fraction is 1%, add 40g vitamin C into 100ml solvent, stir continuously at room temperature, raise the temperature to 50℃ at a constant rate of 0.5℃ / min until the vitamin C is completely dissolved, and then keep the crystal at a constant temperature for 10min. Then cool down to 40℃ at a constant rate of 0.2℃ / min, take samples at intervals of 15min, take samples six times in total, filter and vacuum dry at 60℃ to obtain small-particle vitamin C crystal products.
[0038] The yield of the small-size vitamin C crystal product was calculated to be 90%. Figure 1 The actual pictures of vitamin C (a) prepared in Example 1 of the present invention and the commercially available product (b) show that the sample of Example 1 is white and has good dispersibility, while the commercially available product is light yellow and has poor dispersibility. Figure 4 The SEM images of the vitamin C (a) prepared in Example 1 of the present invention and the commercial product (b) show that the morphology of the vitamin C in Example 1 is a cubic structure; the morphology of the commercially available vitamin C crystal product is irregular, and there are many small crystal particles dispersed on the surface of the large particles, which results in the need for screening in practical applications to obtain the expected small-particle vitamin C crystal product. The XRD spectrum of the small-particle vitamin C crystal product prepared in Example 1 of the present application is shown in FIG. Figure 5 , vitamin C has a stable crystalline structure.
[0039] Malvern Particle Sizer for Particle Size Analysis:
[0040] Using water as the dispersion medium, 1g of vitamin C crystal product was taken to test the particle size at room temperature. The measured range was divided into ten particle sizes, showing the particle size range, channel width and volume fraction of each channel. The results are as follows: Figure 1 As shown. Figure 1 It can be seen that the particle size distribution of the vitamin C crystal product prepared in Example 1 is relatively concentrated, with a main particle size D50 of 95.9 μm and a D90 of 235 μm. The particle size distribution of the commercially available vitamin C crystal product is as follows: Figure 2 As shown, it can be seen that the particle size distribution uniformity of the vitamin C crystal product is poor, with D50 being 159 μm and D90 being 816 μm. This is consistent with the results of the SEM and physical images of the commercially available vitamin C crystal product.
[0041] Purity analysis by HPLC:
[0042] The chromatographic column is an Acutfex YS-NH2 column (250 mm×4.6 mm, 5 μm), the mobile phase is methanol-1% citric acid aqueous solution (80:20, V / V), the flow rate is 1.0 mL / min, the detection wavelength is 254 nm, the column temperature is 30° C., and the injection volume is 10 μL. The vitamin C in Example 1 was tested under the above chromatographic conditions. The results showed that the mass concentration of vitamin C had a good linear relationship with the peak area in the range of 1.01 to 20.16 μg / mL (r=0.999 5, n=6), and the purity was 99.8% by HPLC.
[0043] Stability test:
[0044] The small-particle vitamin C crystal product prepared in Example 1 of the present invention and the commercially available small-particle vitamin C crystal product were sealed and placed at room temperature for 1 month, and the purity was analyzed by the above-mentioned high performance liquid chromatography. The study found that the product in Example 1 of the present invention was still white, not oxidized, and had good stability, with a purity of 99.6%, while the commercially available small-particle vitamin C crystal product turned light yellow, indicating that it had been oxidized and had poor stability, with a purity of 90%.
[0045] Example 2
[0046] Using water-methanol as solvent, the ratio of methanol to water mass fraction is 10%, adding 45g vitamin C to 100ml solvent, stirring continuously at room temperature, heating to 70℃ at a constant speed of 1.0℃ / min until vitamin C is completely dissolved, and then keeping the crystal at a constant temperature for 20min. Then cooling to 30℃ at a constant speed of 0.5℃ / min, sampling at intervals of 15min, sampling six times in total, filtering and vacuum drying at 60℃ to obtain small-particle vitamin C crystal products.
[0047] The yield of the small-size vitamin C crystal product in Example 2 was calculated to be 92%, and the vitamin C had a stable crystalline structure. HPLC test showed that the purity was 99.5%, and the XRD spectrum was shown in FIG. Figure 5 , vitamin C has a stable crystal structure. The stability test found that the product of Example 2 of the present invention is still white, not oxidized and stable, with a purity of 99.3%.
[0048] Example 3
[0049] Using water-ethanol as solvent, the ratio of methanol to water is 5%, add 35g vitamin C to 100ml solvent, stir continuously at room temperature, heat to 60℃ at a constant speed of 0.8℃ / min until vitamin C is completely dissolved, and then keep the crystal at a constant temperature for 30min. Then cool to 40℃ at a constant speed of 0.4℃ / min, take samples at intervals of 15min, take samples six times in total, filter and vacuum dry at 60℃ to obtain small-particle vitamin C crystal products.
[0050] The yield of the small-size vitamin C crystal product in Example 3 was calculated to be 90%. HPLC test showed that the purity was 99%, and the XRD spectrum was shown in Figure 5 , vitamin C has a stable crystal structure. The stability test found that the product of Example 3 of the present invention is still white, not oxidized and stable, with a purity of 98%.
[0051] Comparative Example 1
[0052] Using methanol as solvent, add 40g vitamin C to 100ml methanol, stir continuously at room temperature, and heat to 50℃ at a constant rate of 0.5℃ / min until vitamin C is completely dissolved, then keep the temperature constant for 10min. Then cool to 40℃ at a constant rate of 0.2℃ / min, take samples every 15min, take samples six times in total, filter and vacuum dry at 60℃ to obtain small-size vitamin C crystals.
[0053] The yield of the small-size vitamin C crystal product in Comparative Example 1 was calculated to be 88%, and the HPLC test showed that the purity was 89.5%. The stability test found that the surface of the product in Comparative Example 1 appeared light yellow, and the purity was 85%.
[0054] Comparative Example 2
[0055] Using water as solvent, add 40g vitamin C to 100ml water, stir continuously at room temperature, and heat to 50℃ at a constant rate of 0.5℃ / min until vitamin C is completely dissolved, then keep the temperature constant for 10min. Then cool to 40℃ at a constant rate of 0.2℃ / min, take samples every 15min, take samples six times in total, filter and vacuum dry at 60℃ to obtain small-sized vitamin C crystals.
[0056] The yield of the small-size vitamin C crystal product in Comparative Example 2 was calculated to be 85%, and the HPLC test showed that the purity was 92.5%. The stability test found that the surface of the product in Comparative Example 1 appeared light yellow, and the purity was 90%.
[0057] Comparative Example 3
[0058] Use water-methanol as solvent, the mass fraction ratio of methanol to water is 1%, add 40g vitamin C into 100ml solvent, stir continuously at room temperature, rapidly heat to 50℃ until the vitamin C is completely dissolved, then rapidly cool to 40℃ crystals, take samples at intervals of 15min, take samples six times in total, filter and dry in vacuum at 60℃ to obtain small-particle vitamin C crystal product.
[0059] The yield of the small-size vitamin C crystal product in Comparative Example 3 was calculated to be 86%, and the HPLC test showed that the purity was 86%. The stability test found that the surface of the product in Comparative Example 1 appeared light yellow, and the purity was 83%.
[0060] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Although the present invention is described in detail with reference to the aforementioned embodiments, those skilled in the art can still modify the technical solutions described in the aforementioned embodiments or replace some of the technical features therein by equivalents. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A method for preparing vitamin C crystals with small particle size and uniform morphology, It is characterized in that The small particle size refers to a main particle size D50 of 95 to 100 μm, and the preparation method comprises: Vitamin C is added to the solvent, stirred, and heated to the dissolution temperature; then, the crystals are grown at a constant temperature at the dissolution temperature; then, the temperature is lowered to crystallize, filtered, and dried to obtain a small-size vitamin C crystal product; The solvent is a water-alcohol composite solvent, the alcohol solvent is methanol, ethanol, isopropanol or n-butanol, and the mass fraction of the alcohol solvent in the water-alcohol composite solvent is 1-10%.
2. The preparation method according to claim 1, It is characterized in that The mass ratio of the vitamin C to the solvent is 35-45%.
3. The preparation method according to claim 1, It is characterized in that The dissolving temperature is 50-70° C., and the constant temperature crystal growing time is 10-90 min.
4. The preparation method according to claim 1, It is characterized in that The temperature of the cooling crystal is 30-40°C.
5. The preparation method according to claim 1, It is characterized in that The temperature rise is a constant rate temperature rise, and the constant rate temperature rise is 0.5-1.0°C / min.
6. The preparation method according to claim 1, It is characterized in that The cooling is performed at a constant rate, and the constant rate of cooling is 0.2-0.4°C / min.
7. The preparation method according to claim 1, It is characterized in that The preparation method comprises: Use water-methanol as solvent, the mass fraction ratio of methanol to water is 1-10%, weigh 35-45% of vitamin C in the solution system, add it into a crystallizer, and heat it to 50-70°C at a constant rate of 0.5-1.0°C / min under stirring until the vitamin C is dissolved, then grow the crystal at a constant temperature for 15-90min; then cool it to 30-40°C at a constant rate of 0.2-0.4°C / min, filter it and vacuum dry it at 30-60°C for 5h to obtain a small-particle vitamin C crystal product.
8. The preparation method according to claim 1, It is characterized in that The stirring speed is 200 rpm / min to 300 rpm / min.
9. Vitamin C crystals with small particle size and uniform morphology obtained by the preparation method according to claim 1, It is characterized in that The main particle size D50 of the small-sized vitamin C is 95-100 μm; the morphology of the small-sized vitamin C is a cubic structure.
10. Use of the vitamin C crystals with small particle size and uniform morphology as claimed in claim 9 in pharmaceutical preparations or food additives.
